Reportstack

MultiCell Technologies, Inc. - Product Pipeline Review - 2012 New Report

 

Naperville, IL -- (ReleaseWire) -- 09/25/2012 -- MultiCell Technologies, Inc. - Product Pipeline Review - 2012 provides data on the MultiCell Technologies, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- MultiCell Technologies, Inc. - Brief MultiCell Technologies, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of MultiCell Technologies, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of MultiCell Technologies, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the MultiCell Technologies, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate MultiCell Technologies, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of MultiCell Technologies, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the MultiCell Technologies, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with MultiCell Technologies, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of MultiCell Technologies, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of MultiCell Technologies, Inc.; MultiCell Technologies, Inc. - Key Therapeutics; MultiCell Technologies, Inc. - Pipeline Overview and Promising Molecules; MultiCell Technologies, Inc. - News; MultiCell Technologies, Inc. - Latest Updates; MultiCell Technologies, Inc. - Pipeline; MultiCell Technologies, Inc. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/89992/multicell-technologies-inc-product-pipeline-review-2012.html